Radiation and interventional procedures for multiple sclerosis: choosing a specific treatment target

An MRI report showing several brain lesions can make focused radiation sound like a direct solution. Multiple sclerosis is not ordinarily managed by irradiating each visible lesion. Its inflammatory activity, relapses and lasting functional difficulties require different forms of care. A procedure may nevertheless help a particular problem, such as treatment-resistant facial pain, severe spasticity or impaired bladder storage. Before consenting, ask the team to name the symptom being treated and the daily activity they expect to improve. That makes it possible to judge the proposed intervention alongside disease-modifying treatment and rehabilitation. NICE guidance on MS management

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

An appointment in a radiology department does not necessarily involve radiation treatment. MRI evaluates the nervous system and supports diagnosis or monitoring; the examination is not itself therapy for MS. The requested body region, comparison with previous scans and use of contrast should answer a clinical question. A translated itinerary should distinguish an MRI examination, a CT scan, treatment-planning imaging and an actual therapeutic procedure. Confusing these steps can leave patients believing that a treatment has already been agreed when the hospital has only booked an assessment. The 2024 MRI consensus, published in 2025
Urgency and leakage can make working, travelling and leaving home difficult. Their cause should be assessed before treatment is selected. A patient may have impaired storage, difficulty emptying, infection or a combination of problems. For selected adults with MS and overactive bladder symptoms, or impaired storage demonstrated on urodynamic testing, bladder-wall botulinum toxin A may be considered when antimuscarinic medicines have not worked adequately or are poorly tolerated. An isolated count of leakage episodes is not a complete assessment. NICE guidance on neurological urinary dysfunction
A suitable service connects the neurological assessment with the specialty performing the procedure. Provide the current medication list, infection history, allergies, anticoagulants and implanted-device details. The treating team should decide whether medicine timing or additional assessment is needed; patients should not stop prescriptions simply because an operation has been mentioned. An international guideline does not establish that a particular device or indication is available at a Chinese hospital.

Quick answer

Full guide

Start by separating imaging from treatment

An appointment in a radiology department does not necessarily involve radiation treatment. MRI evaluates the nervous system and supports diagnosis or monitoring; the examination is not itself therapy for MS. The requested body region, comparison with previous scans and use of contrast should answer a clinical question. A translated itinerary should distinguish an MRI examination, a CT scan, treatment-planning imaging and an actual therapeutic procedure. Confusing these steps can leave patients believing that a treatment has already been agreed when the hospital has only booked an assessment. The 2024 MRI consensus, published in 2025

Stereotactic radiosurgery delivers focused radiation to a defined target. In an appropriate patient it may be considered for trigeminal neuralgia, a severe facial pain disorder that can occur with MS. This does not mean that the treatment controls inflammatory lesions elsewhere. Decisions about ongoing MS medication and surveillance still belong in the neurological care plan. If a proposal describes eliminating lesions without identifying the target, indication and expected clinical benefit, ask the treating physician to explain those terms before arranging travel.

It is useful to bring two separate goals to the consultation: what the procedure should change, and what the MS team will continue monitoring. Someone may have less facial pain while their walking still requires assessment. Another person may have stable MRI findings yet need substantial help with bladder function. Keeping these goals visible prevents an improvement in one area from being mistaken for a complete assessment of the disease.

Facial pain needs a diagnosis before a procedural choice

Brief, severe attacks triggered by brushing teeth, speaking or touching the face can make eating difficult. However, having MS does not establish that every new facial pain is trigeminal neuralgia. Dental disease and other pain disorders need consideration. Assessment includes the pattern of attacks, triggers, examination and appropriate MRI. A blood vessel touching the nerve on a scan is not, by itself, enough to explain every pain syndrome or select an operation. European Academy of Neurology trigeminal neuralgia guideline

When medication provides insufficient relief or causes unacceptable adverse effects, a specialist may discuss neurosurgical options or radiosurgery. The relevance of microvascular decompression is assessed individually in MS-related disease; results from uncomplicated classical trigeminal neuralgia should not be presented as a personal forecast. The consultation should include previous nerve procedures, existing facial numbness, eye symptoms and current medicines. Earlier treatment can change the consequences of another intervention, particularly when sensation is already impaired.

A small retrospective study published in 2024 reported pain improvement in some patients with MS-related trigeminal neuralgia after Gamma Knife treatment, alongside recurrent pain and complications including sensory disturbance and reduced corneal reflex. Its findings support a discussion of trade-offs, rather than a guaranteed result. Response may take time, and the study's definition of adequate pain control can include continued medication. It is therefore important to clarify what a hospital means by success. Original 2024 clinical study

For a patient travelling to China, the waiting period after treatment is part of the plan. Who manages severe attacks before the procedure takes effect? Which clinician adjusts the existing prescription? If eye sensation changes, where should the patient obtain an examination? These questions can be answered before departure. A short hospital stay does not establish that the benefit is immediate or that later medical care will be unnecessary.

When comparing proposals, ask about the duration of follow-up, medication use after treatment, recurrent pain and the consequences of repeat procedures. A quoted relief rate without these details is difficult to interpret. The best fit also depends on the person's priorities: tolerating some numbness, avoiding an invasive operation, reducing medication or being able to eat comfortably may carry different weights for different people.

Spasticity procedures should improve a task that matters

Severe stiffness or spasms can interfere with sleep, sitting, personal care and transfers. Before escalating treatment, the team should assess triggers, previous oral medicines and the way muscle tone contributes to function. Some people use stiffness to support standing or movement. Reducing it too far can make a transfer harder even when the examination shows less spasticity. A useful goal might be sitting comfortably through a meal or making turning in bed easier for both the patient and caregiver. NICE recommendations on spasticity and function

An intrathecal baclofen pump is an ongoing drug-delivery system. Implantation starts a schedule of refills, checks and technical support. The official intrathecal baclofen information warns that abrupt interruption can cause severe withdrawal, including high fever, altered mental state and marked rebound spasticity, with potentially life-threatening complications. Overdose is also dangerous. Patients should not change programming themselves or attempt an oral replacement using an internet dose conversion. DailyMed intrathecal baclofen prescribing information

Before having a pump implanted abroad, establish whether a team at home can support the exact device and medication preparation. Carry the device identification, medicine concentration, current settings and scheduled refill date. The emergency plan should remain available if flights are cancelled or the usual caregiver is absent. A pump alarm or sudden clinical deterioration needs prompt assessment by professionals who know that a continuous drug-delivery system is present.

The financial discussion should reflect this continuing relationship. The implantation fee alone does not describe refill visits, travel to a qualified service, replacement parts or unscheduled assessment. Ask the Chinese hospital to identify which services it will provide after discharge and which arrangements must be made locally. A proposed device should not be treated as a self-contained purchase when its safe use depends on recurring clinical support.

Bladder injections involve both storage and emptying

Urgency and leakage can make working, travelling and leaving home difficult. Their cause should be assessed before treatment is selected. A patient may have impaired storage, difficulty emptying, infection or a combination of problems. For selected adults with MS and overactive bladder symptoms, or impaired storage demonstrated on urodynamic testing, bladder-wall botulinum toxin A may be considered when antimuscarinic medicines have not worked adequately or are poorly tolerated. An isolated count of leakage episodes is not a complete assessment. NICE guidance on neurological urinary dysfunction

The possibility of needing catheterisation should be discussed before an injection. A person who previously emptied their bladder independently may require additional support afterwards. Monitoring residual urine is part of care when a catheterisation regimen is not already in use. The patient's hand function, vision, understanding and home environment affect what can realistically be managed. Someone expected to help should have the opportunity to learn the technique and agree to the role. NICE information for patients on bladder storage treatment

For an international patient, these arrangements should not be postponed until the return flight. The team can demonstrate supplies, identify a locally obtainable specification and set out where residual urine will be checked. Discuss what happens when symptoms return and whether another injection would require reassessment. A successful initial procedure can still create practical problems if the patient cannot obtain consumables or reach a clinician later.

If current home support is insufficient, alternatives or additional training can be discussed before committing. Deferring an intervention while these details are resolved leaves room for a better prepared choice. The point is to make relief from leakage compatible with safe and workable bladder emptying, rather than judging the outcome only by the disappearance of one symptom.

Electrical stimulation for foot drop: test it in ordinary walking

Functional electrical stimulation can assist selected people with foot drop due to a central neurological condition. NICE considers the evidence for improving gait sufficient for use with appropriate clinical arrangements, and recommends specialist multidisciplinary selection for implantable systems. The goal is functional assistance. This evidence does not establish that stimulation repairs myelin or prevents later MS progression. NICE recommendations on functional electrical stimulation

A useful assessment includes more than a brief walk for a demonstration video. The person can try their usual shoes, turn, approach a doorway and repeat a manageable task after some activity. Record whether the device is comfortable, whether putting it on is practical and whether it helps with the task that caused difficulty. Compare it with an ankle-foot orthosis, rehabilitation and other available support. Preferences about appearance, effort and maintenance can determine whether a technically effective device is actually used.

Evidence about a named product also needs careful reading. A NICE technology briefing on ODFS Pace distinguishes effects while the device is assisting walking from changes measured without it. Better performance with stimulation switched on does not automatically mean the same improvement will persist after the device is removed. A technology briefing is also different from a general clinical treatment recommendation. NICE review of the ODFS Pace evidence

If obtaining a device in China, confirm its model, intended use, fitting service, electrode supplies and repair pathway. Similar names do not guarantee interchangeable components or overseas support. An implanted system should involve a clear clinical assessment and an aftercare arrangement, rather than a purchase made only because a travel opportunity is available. Keep room in the budget for ongoing neurological review and rehabilitation.

Venous angioplasty is not an MS disease treatment

Balloon dilation of neck or azygos veins for proposed chronic cerebrospinal venous insufficiency has been promoted as a way to treat MS. A randomised, double-blind, sham-controlled trial did not support benefit in patient-reported, standard clinical or MRI outcomes. NICE likewise advises against using this procedure to manage MS because the evidence shows no benefit and the possibility of serious complications. Original sham-controlled trial and NICE venoplasty recommendation

A separate vascular diagnosis may warrant its own assessment, but finding venous narrowing does not establish that it caused the patient's MS. If a package promises improved cerebral circulation or release of blocked veins, request evidence linked to the actual diagnosis and proposed outcome. A short-term testimonial cannot answer whether disease activity or disability changed because of the procedure. Promotional wording should be translated into a claim that a clinician can evaluate.

Make the Chinese treatment pathway specific enough to follow

A suitable service connects the neurological assessment with the specialty performing the procedure. Provide the current medication list, infection history, allergies, anticoagulants and implanted-device details. The treating team should decide whether medicine timing or additional assessment is needed; patients should not stop prescriptions simply because an operation has been mentioned. An international guideline does not establish that a particular device or indication is available at a Chinese hospital.

Before booking the intervention, request a written description of the target, alternatives, delayed adverse effects, review schedule and contact arrangements. Cost information should include follow-up programming, consumables or repeat treatment where relevant. There is no single reliable price for this collection of very different procedures. A hospital-specific, itemised estimate is more useful than an unsupported national figure.

The decision to travel should rest on whether the complete course is feasible: appropriate selection, the procedure itself, early observation and continuing care after returning home. A family may reasonably choose a less burdensome option if it meets the same functional goal. What matters is that the expected benefit is understandable and that the patient knows who will help when the next stage of care arrives.